Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female patients 18 to 85 years of age with suspected and/or bacteriologically documented complicated UTI judges by the investigator to be serious (required patient to be hospitalized for treatment with intravenous antibiotics)
You may not be if
Urine Gram stain that demonstrated that a Gram-positive organism was present, or if urine culture results were available, demonstrated Gram- positive organisms were present at ≥10E5 CFU/mL
Urine culture result available at enrollment and demonstrating more than 2 different species of microorganisms regardless of the colony count
Urine culture result available demonstrating fungal UTI with colony count \>10E3 CFU/mL
Patient had received prior antibiotics within 72 hours before the initiation of study therapy
Patients with estimated glomerular filtration rate \< 30mL/min calculated based in study qualified formula
Clareo Health | LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)
